healthneutral
Weight Loss Wins: Five Years of Diabetes Relief and Money Saved
United Kingdom, SheffieldSunday, March 29, 2026
Program Overview
- Name: Counterweight‑Plus
- Origin: DiRECT diabetes trial
- Duration studied: 5 years
Key Findings
| Metric | Value |
|---|---|
| Average weight loss | 6.1 kg |
| % no longer on medication | 10% |
Economic Impact
- Long‑term savings from reduced drug use, fewer hospital visits, and lower complication rates.
- Despite extra coaching, diet plans, and monitoring time, the program remains cheaper than standard treatments.
- Savings stem from both lower medical bills and the intrinsic value of healthier, longer lives.
Implications
- Investing in sustained weight‑loss programs can benefit patients and insurers alike.
- The evidence supports that a modest, maintained weight loss reduces the overall burden of type 2 diabetes.
Actions
flag content